Image For Activity Cover
ORN Spring 2022 #5 - The Fourth Wave: Addressing the Intertwined Fentanyl and Stimulant Overdose Crisis
Available on-demand. Login or create an account to register to view the recording.

This course was originally offered as part of "ORN - Hot Topics in Addiction Medicine - Spring 2022 Webinar Series (On-Demand)" course. If you took or registered for that course, you will not be able to access this course.
Learning Objectives
At the conclusion of this webinar, attendees will be able to:
  • Recall the history and epidemiology of overdose due to opioids (the “triple wave”) and stimulants (“the fourth wave”)
  • Explain two poly-drug use patterns involving synthetic opioids and methamphetamine and develop treatment strategies
  • Propose three harm reduction measures to prevent overdose deaths due to synthetic opioids
Claim Credit & Course Material

How to claim your credits & download handouts for each webinar:

Under the "Course" tab (or "Content" tab):
  1. Complete the required course materials.
  2. Claim your credits by clicking the "Report Credit" or "Request Credit" button on the right above the course materials.
Credit Statement
This webinar has been approved for a maximum 1, AOA Category 1-A CME credits, and AOA designates this for a maximum of 1, AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of the extent of their participation. This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Osteopathic Association (AOA) and AOAAM. The AOA is accredited by the ACCME to provide continuing medical education for physicians.

Daniel Ciccarone, MD

Dr. Dan Ciccarone is the Justine Miner Professor in Addiction Medicine in the department of Family and Community Medicine at UCSF. He has been principal or co-investigator on numerous NIH sponsored public health research projects including his current Synthetics in Combination (SYNC) study. He is a recognized international scholar on the medical, public health and public policy dimensions of substance use, risks and consequences. He is Associate Editor for the International Journal of Drug Policy and recently edited an IJDP special issue on the “triple wave crisis” of opioids, heroin and fentanyl in the US. He consults for numerous private and public entities including the ONDCP, CDC and FDA.

Availability: On-Demand
Expires on Apr 30, 2025
Cost: FREE
Credit Offered:
1 AMA PRA Category 1 Credit
1 AOA Category 1A Credit
Powered By